PharmaStem Wins Judgment in Umbilical-Cord Patent Case

Law360, New York (November 3, 2003, 12:00 AM EST) -- A jury in the U.S. District Court for the District of Delaware has found that several of the nation's largest umbilical-cord blood banks willfully violated patents covering the medically valuable tissues, the Wall Street Journal reported on Monday.

The jury stipulated a "reasonable royalty rate" of 6.125% and awarded the plaintiff $7.1 million, according to court records.

On Feb. 22, 2002, PharmaStem Therapeutics Inc., of Wayne, Pa., sued ViaCell Inc., Boston; Cryo-Cell International Inc., Clearwater, Fla.; CorCell Inc., Philadelphia; and CBR Systems Inc., San Bruno, Calif,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.